<DOC>
	<DOCNO>NCT01617473</DOCNO>
	<brief_summary>The use peripheral blood stem cell ( PBSCs ) rapidly grow allogeneic transplantation set alternative bone marrow ( BM ) .It find use PBSCs associate faster hematologic recovery yield differ result regard incidence graft-versus-host-disease ( GVHD ) relapse . The study hypothesis : transplantation mobilize PBSC haploidentical donor standard-risk leukemia comparable engraftment non-relapse mortality mobilize BM combine PBSCs</brief_summary>
	<brief_title>Randomized Trial Mobilized Blood/Marrow Versus Blood Transplant</brief_title>
	<detailed_description>The donor prim granulocyte-colony stimulating factor ( G-CSF ) inject subcutaneously five consecutive day . In trial group , PBSCs harvest fourth fifth day ; control group , bone marrow cell harvest fourth day PBSCs harvest fifth day .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<criteria>Standard risk Recipients haploidentical stem cell transplantation myeloablative conditioning regimen Active , uncontrolled infection</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>